Wendel Growth
VC Fund
Wendel Growth is an investment arm of Wendel.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Wendel Growth invests in
Stages Wendel Growth invests in
Countries Wendel Growth invests in
Round sizes
Round size
- Series A
- $33M–$38M
- Venture - Series Unknown
- $16M–$16M
Investment Focus
Industry
- Analytics 1 (17%)
- Open Source 1 (17%)
- Biotechnology 1 (17%)
- Online Portals 1 (17%)
- Pharmaceutical 1 (17%)
Stage
- Series A 1 (17%)
- Funding Round 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- France 1 (17%)
- Luxembourg 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TaDaweb
|
Tadaweb provides open-source intelligence (OSINT) platforms that enable organizations to generate actionable intelligence by optimizing analysts' investigative methods, reducing time to insight from days to minutes. Tadaweb's platforms scale analysts' expertise across the internet's vast, volatile reaches. The company wasfounded in 2011 and is headquartered in Luxembourg and has offices in Paris, London, and Ottawa. | $19.9M / Jun 19, 2025 | |
|
TaDaweb
|
Tadaweb provides open-source intelligence (OSINT) platforms that enable organizations to generate actionable intelligence by optimizing analysts' investigative methods, reducing time to insight from days to minutes. Tadaweb's platforms scale analysts' expertise across the internet's vast, volatile reaches. The company wasfounded in 2011 and is headquartered in Luxembourg and has offices in Paris, London, and Ottawa. | $19.9M / Jun 19, 2025 | |
AQEMIA
|
AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AIand atomic scale physics, to design novel drugs tailored for specific therapeutic targets. | $38M / Series A / Dec 10, 2024 | |
|
AQEMIA
|
AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AIand atomic scale physics, to design novel drugs tailored for specific therapeutic targets. | $32.5M / Series A / Jan 30, 2024 | |
|
TaDaweb
|
Tadaweb provides open-source intelligence (OSINT) platforms that enable organizations to generate actionable intelligence by optimizing analysts' investigative methods, reducing time to insight from days to minutes. Tadaweb's platforms scale analysts' expertise across the internet's vast, volatile reaches. The company wasfounded in 2011 and is headquartered in Luxembourg and has offices in Paris, London, and Ottawa. | $15.9M / Venture - Series Unknown / Jan 04, 2023 | |
|
TaDaweb
|
Tadaweb provides open-source intelligence (OSINT) platforms that enable organizations to generate actionable intelligence by optimizing analysts' investigative methods, reducing time to insight from days to minutes. Tadaweb's platforms scale analysts' expertise across the internet's vast, volatile reaches. The company wasfounded in 2011 and is headquartered in Luxembourg and has offices in Paris, London, and Ottawa. | $15.9M / Venture - Series Unknown / Jan 04, 2023 |
Co-Investors
Eurazeo
3 deals together
Arsenal Growth Equity
2 deals together
Elaia
2 deals together
Forgepoint Capital International
2 deals together
Bpifrance
1 deal together
Bpifrance Large Venture
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Wendel Growth invest in?
Wendel Growth invests primarily in Analytics, Open Source and Biotechnology startups, most often at Series A and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Wendel Growth's check size?
Wendel Growth typically joins rounds of $33M–$38M at Series A and $16M–$16M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wendel Growth participates in.
When did Wendel Growth last invest?
The most recent investment recorded for Wendel Growth closed in Jun 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
